Enhanced dendritic availability of μ‐opioid receptors in inhibitory neurons of the extended amygdala in mice deficient in the corticotropin‐releasing factor‐1 receptor
Abstract
Activation of the corticotropin‐releasing factor‐1 (CRF‐1) receptor in the anterolateral BNST (BSTal), a key subdivision of the extended amygdala, elicits opiate‐seeking behavior exacerbated by stress. However, it is unknown whether the presence of CRF‐1 affects expression of the μ‐opioid receptor (μ‐OR) in the many GABAergic BSTal neurons implicated in the stress response. We hypothesized that deletion of the CRF‐1 receptor gene would alter the density and/or subcellular distribution of μ‐ORs in GABAergic neurons of the BSTal. We used electron microscopy to quantitatively examine μ‐OR immunogold and γ‐aminobutyric acid (GABA) immunoperoxidase labeling in the BSTal of CRFr‐1 knockout (KO) compared to wild‐type (WT) mice. To assess regional specificity, we examined μ‐OR distribution in dorsal striatum. The μ‐ORs in each region were predominantly localized in dendrites, many of which were GABA‐immunoreactive. Significantly, more cytoplasmic μ‐OR gold particles per dendritic area were observed selectively in GABA‐containing dendrites of the BSTal, but not of the dorsal striatum, in KO compared to WT mice. In both regions, however, significantly fewer GABA‐immunoreactive axon terminals were present in KO compared to WT mice. Our results suggest that the absence of CRF‐1 results in enhanced expression and/or dendritic trafficking of μ‐ORs in inhibitory BSTal neurons. They also suggest that the expression of CRF‐1 is a critical determinant of the availability of GABA in functionally diverse brain regions. These findings underscore the complex interplay between CRF, opioid, and GABA systems in limbic and striatal regions and have implications for the role of CRF‐1 in influencing the pharmacological effects of opiates active at μ‐ORs. Synapse 65:8–20, 2011.Keywords
This publication has 90 references indexed in Scilit:
- Subcellular plasticity of the corticotropin-releasing factor receptor in dendrites of the mouse bed nucleus of the stria terminalis following chronic opiate exposureNeuroscience, 2009
- A Discrete GABAergic Relay Mediates Medial Prefrontal Cortical Inhibition of the Neuroendocrine Stress ResponseThe Journal of Neuroscience, 2009
- Mu-opioid and corticotropin-releasing-factor receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central amygdala and bed nucleus of the stria terminalisNeuroscience, 2009
- Dopamine Enhances Fast Excitatory Synaptic Transmission in the Extended Amygdala by a CRF-R1-Dependent ProcessJournal of Neuroscience, 2008
- Corticotropin-Releasing Factor Increases GABA Synaptic Activity and Induces Inward Current in 5-Hydroxytryptamine Dorsal Raphe NeuronsJournal of Neuroscience, 2008
- Electron microscopic localization of corticotropin‐releasing factor (CRF) and CRF receptor in rat and mouse central nucleus of the amygdalaJournal of Comparative Neurology, 2008
- Type 1 corticotropin‐releasing factor receptor expression reported in BAC transgenic mice: Implications for reconciling ligand‐receptor mismatch in the central corticotropin‐releasing factor systemJournal of Comparative Neurology, 2008
- Region-Specific Changes in the Subcellular Distribution of AMPA Receptor GluR1 Subunit in the Rat Ventral Tegmental Area after Acute or Chronic Morphine AdministrationThe Journal of Neuroscience, 2008
- Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behaviorJournal of Psychopharmacology, 2008
- Dendritic distributions of dopamine D1 receptors in the rat nucleus accumbens are synergistically affected by startle-evoking auditory stimulation and apomorphineNeuroscience, 2007